Tilray

TLRYPhase 3

Tilray is a diversified, multi-national cannabis and consumer packaged goods company formed through the merger of Tilray and Aphria in 2021. It holds a significant market share in the Canadian adult-use cannabis market and has expanded its portfolio through strategic acquisitions, including HEXO, Truss Beverage Co., and Breckenridge Distillery. The company's strategy focuses on leveraging its cultivation, manufacturing, and distribution capabilities across its core business units to drive growth in both the cannabis and non-cannabis CPG sectors.

Market Cap

$723.5M

Employees

2000-2500

Focus

Biotech

TLRY · Stock Price

USD 6.2179.39 (-92.75%)

Historical price data

AI Company Overview

Technology Platform

Vertically integrated cannabis cultivation, extraction, and manufacturing platform with GMP-certified facilities, focusing on advanced agricultural techniques, product formulation, and a global supply chain.

Pipeline Snapshot

8 drugs in pipeline, 1 in Phase 3

Drug	Indication	Stage
Cannabidiol (CBD) Oil Capsules + Sunflower Lecithin Oil in Capsule	Generalized Anxiety Disorder	Phase 3
TN-TC11M2 oral capsules (THC 2.5 mg/CBD 2.5 mg) + TN-C200M2 oral capsules (CBD 2...	HIV Infections	Phase 2
High THC/Low CBD Cannabis + High THC/High CBD Cannabis + Low THC/Low CBD Cannabi...	Posttraumatic Stress Disorder	Phase 2
CBD/THC + Placebo oral capsule	Essential Tremor	Phase 1/2
TN-TC11G + Temozolomide Oral Product	Glioblastoma	Phase 1/2

Opportunities

The primary growth opportunities include U.S.

federal cannabis legalization, expansion into new international medical and adult-use markets, and leveraging its CPG platform for cross-selling and new product innovation.

The company is well-positioned to be a consolidator in a fragmented industry.

Risk Factors

Key risks include persistent regulatory uncertainty, intense competition and price pressure in core markets, execution risk on integrating multiple acquisitions, and the ongoing threat from the illicit cannabis market.

The company's performance remains heavily tied to the volatile cannabis sector sentiment.

Competitive Landscape

Tilray competes with large Canadian licensed producers (Canopy, Aurora), U.S. multi-state operators (though indirectly), and major CPG companies in beverage alcohol and wellness. Its key differentiators are its global medical footprint, diversified revenue base, and strong balance sheet relative to peers.

Publications

Patents

Pipeline